INBX

Inhibrx, Inc. Common Stock
INBX

Overview Fund Activity
Delisted

INBX was delisted on the 29th of May, 2024.

Back to rankings

108 hedge funds and large institutions have $692M invested in Inhibrx, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 23 closing their positions.

Holders
108
Holders Change
-8
Holders Change %
-6.9%
% of All Funds
1.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
37
Reduced
34
Closed
23
Calls
$4.19M
Puts
$93K
Net Calls
+$4.1M
Net Calls Change
+$6.72M

Top Buyers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$33.1M
2
WP
2
Woodline Partners
California
$5.93M
3
PA
3
Perceptive Advisors
New York
$68.2M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$4.03M
5
Loomis, Sayles & Company
5
Loomis, Sayles & Company
Massachusetts
$21.9M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$1.94M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$4.51M
3
State Street
3
State Street
Massachusetts
$39.2M
4
ACH
4
ArrowMark Colorado Holdings
Colorado
$17.8M
5
TCM
5
Tybourne Capital Management
Hong Kong
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Viking Global Investors
1
Viking Global Investors
Connecticut
$125M 6,639,199 – –
RCM
2
RA Capital Management
Massachusetts
$72.7M 3,853,867 – –
PA
3
Perceptive Advisors
New York
$68.2M 3,615,383 +301,600 +9%
BlackRock
4
BlackRock
New York
$44M 2,332,925 -83,263 -3%
State Street
5
State Street
Massachusetts
$39.2M 2,075,990 -430,998 -17%
Vanguard Group
6
Vanguard Group
Pennsylvania
$33.5M 1,775,281 +14,908 +0.8%
Capital Research Global Investors
7
Capital Research Global Investors
California
$33.1M 1,751,913 +1,751,913 New
Fidelity Investments
8
Fidelity Investments
Massachusetts
$30.4M 1,609,027 -81,608 -5%
SI
9
Sofinnova Investments
California
$23.5M 1,244,488 +134,305 +12%
MB
10
MPM BioImpact
Massachusetts
$22.5M 1,192,281 -94,154 -7%
Loomis, Sayles & Company
11
Loomis, Sayles & Company
Massachusetts
$21.9M 1,161,982 +161,176 +16%
ACH
12
ArrowMark Colorado Holdings
Colorado
$17.8M 941,423 -197,914 -17%
Millennium Management
13
Millennium Management
New York
$13.6M 719,553 +21,717 +3%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$11.5M 609,817 +34,120 +6%
SCM
15
Soleus Capital Management
Connecticut
$8.27M 438,002 -40,300 -8%
Morgan Stanley
16
Morgan Stanley
New York
$7.1M 376,220 +119,202 +46%
Two Sigma Investments
17
Two Sigma Investments
New York
$6.34M 335,803 +89,802 +37%
Schroder Investment Management Group
18
Schroder Investment Management Group
United Kingdom
$6.06M 321,389 -53,686 -14%
Russell Investments Group
19
Russell Investments Group
United Kingdom
$6.01M 318,505 -1,040 -0.3%
Northern Trust
20
Northern Trust
Illinois
$6M 318,126 +6,139 +2%
WP
21
Woodline Partners
California
$5.93M 314,195 +314,195 New
Two Sigma Advisers
22
Two Sigma Advisers
New York
$5.17M 273,900 +67,100 +32%
Charles Schwab
23
Charles Schwab
California
$4.56M 241,701 -6,221 -3%
Point72 Asset Management
24
Point72 Asset Management
Connecticut
$4.51M 239,119 -513,381 -68%
PIM
25
Platinum Investment Management
Australia
$4.19M 222,209 +62,082 +39%
1
2 3 4 5